207 related articles for article (PubMed ID: 26534874)
21. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.
George RB; McKeen D; Chaplin AC; McLeod L
Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255
[TBL] [Abstract][Full Text] [Related]
22. A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery.
Ragab A; Barakat R; Alsammani MA
Int J Gynaecol Obstet; 2016 Jan; 132(1):82-4. PubMed ID: 26522140
[TBL] [Abstract][Full Text] [Related]
23. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial.
Diop A; Daff B; Sow M; Blum J; Diagne M; Sloan NL; Winikoff B
Lancet Glob Health; 2016 Jan; 4(1):e37-44. PubMed ID: 26718808
[TBL] [Abstract][Full Text] [Related]
24. Adjunctive rectal misoprostol versus oxytocin infusion for prevention of postpartum hemorrhage in women at risk: a randomized controlled trial.
Badejoko OO; Ijarotimi AO; Awowole IO; Loto OM; Badejoko BO; Olaiya DS; Fatusi AO; Kuti O; Orji EO; Ogunniyi SO
J Obstet Gynaecol Res; 2012 Nov; 38(11):1294-301. PubMed ID: 22612662
[TBL] [Abstract][Full Text] [Related]
25. The effect of post-cesarean rectal misoprostol on intestinal motility.
Adanikin AI; Orji EO; Fasubaa OB; Onwudiegwu U; Ijarotimi OA; Olaniyan O
Int J Gynaecol Obstet; 2012 Nov; 119(2):159-62. PubMed ID: 22925817
[TBL] [Abstract][Full Text] [Related]
26. Effects of preoperative sublingual misoprostol on uterine tone during isoflurane anesthesia for cesarean section.
El Tahan MR; Warda OM; Rashad A; Yasseen AM; Ramzy EA; Ahmady MS; Diab DG; Matter MK
Rev Bras Anestesiol; 2012; 62(5):625-35. PubMed ID: 22999396
[TBL] [Abstract][Full Text] [Related]
27. Randomized controlled trial comparing 200μg and 400μg sublingual misoprostol for prevention of primary postpartum hemorrhage.
Ugwu IA; Oluwasola TA; Enabor OO; Anayochukwu-Ugwu NN; Adeyemi AB; Olayemi OO
Int J Gynaecol Obstet; 2016 May; 133(2):173-7. PubMed ID: 26892695
[TBL] [Abstract][Full Text] [Related]
28. Impact of a third stage of labor oxytocin protocol on cesarean delivery outcomes.
Lee AI; Wong CA; Healy L; Toledo P
Int J Obstet Anesth; 2014 Feb; 23(1):18-22. PubMed ID: 24332518
[TBL] [Abstract][Full Text] [Related]
29. Misoprostol to reduce intraoperative and postoperative hemorrhage during cesarean delivery: a systematic review and metaanalysis.
Conde-Agudelo A; Nieto A; Rosas-Bermudez A; Romero R
Am J Obstet Gynecol; 2013 Jul; 209(1):40.e1-40.e17. PubMed ID: 23507545
[TBL] [Abstract][Full Text] [Related]
30. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
Chaudhuri P; Biswas J; Mandal A
Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
[TBL] [Abstract][Full Text] [Related]
31. Calcium chloride for the prevention of uterine atony during cesarean delivery: A pilot randomized controlled trial and pharmacokinetic study.
Ansari JR; Kalariya N; Carvalho B; Flood P; Guo N; Riley E
J Clin Anesth; 2022 Sep; 80():110796. PubMed ID: 35447502
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic Administration of Uterotonics to Prevent Postpartum Hemorrhage in Women Undergoing Cesarean Delivery for Arrest of Labor: A Randomized Controlled Trial.
Balki M; Downey K; Walker A; Seaward G; Carvalho JCA
Obstet Gynecol; 2021 Mar; 137(3):505-513. PubMed ID: 33543897
[TBL] [Abstract][Full Text] [Related]
33. Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon.
Lokugamage AU; Paine M; Bassaw-Balroop K; Sullivan KR; Refaey HE; Rodeck CH
Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):411-4. PubMed ID: 11787915
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of intrauterine misoprostol during cesarean section in prevention of primary PPH, a randomized controlled trial.
Alalfy M; Lasheen Y; Elshenoufy H; Elzahaby IM; Kaleem HW; El Sawah H; Azkalani A; Saber W; Rashwan ASSA
J Matern Fetal Neonatal Med; 2020 May; 33(9):1459-1465. PubMed ID: 30176758
[No Abstract] [Full Text] [Related]
35. A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage.
Priya GP; Veena P; Chaturvedula L; Subitha L
Arch Gynecol Obstet; 2015 Dec; 292(6):1231-7. PubMed ID: 25990482
[TBL] [Abstract][Full Text] [Related]
36. The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study.
Lavoie A; McCarthy RJ; Wong CA
Anesth Analg; 2015 Jul; 121(1):159-164. PubMed ID: 25902327
[TBL] [Abstract][Full Text] [Related]
37. Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.
Nasr A; Shahin AY; Elsamman AM; Zakherah MS; Shaaban OM
Int J Gynaecol Obstet; 2009 Jun; 105(3):244-7. PubMed ID: 19249048
[TBL] [Abstract][Full Text] [Related]
38. Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery.
Lapaire O; Schneider MC; Stotz M; Surbek DV; Holzgreve W; Hoesli IM
Int J Gynaecol Obstet; 2006 Oct; 95(1):2-7. PubMed ID: 16934269
[TBL] [Abstract][Full Text] [Related]
39. Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor.
Singh G; Radhakrishnan G; Guleria K
Int J Gynaecol Obstet; 2009 Nov; 107(2):130-4. PubMed ID: 19628206
[TBL] [Abstract][Full Text] [Related]
40. Lack of controlled studies investigating the risk of postpartum haemorrhage in cesarean delivery after prior use of oxytocin: a scoping review.
Bischoff K; Nothacker M; Lehane C; Lang B; Meerpohl J; Schmucker C
BMC Pregnancy Childbirth; 2017 Nov; 17(1):399. PubMed ID: 29187156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
